PRICE T ROWE ASSOCIATES INC /MD/
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$591,157
+$217,802 QoQ
Shares Held
29,367
+27.0% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 182 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. KALV ranks #172 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in KALV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $591,157 | 29,367 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $373,355 | 23,118 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $243,356 | 19,980 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $201,952 | 17,864 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $194,137 | 16,823 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $117,216 | 13,839 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $151,894 | 13,117 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $298,646 | 25,352 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $262,604 | 22,142 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $259,675 | 21,198 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $182,594 | 18,961 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $292,644 | 32,516 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $290,592 | 36,971 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $249,302 | 36,879 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $390,986 | 26,946 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $206,630 | 20,999 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $270,139 | 18,327 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $193,965 | 14,661 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||